Query: NC_015259:485015 Polymorphum gilvum SL003B-26A1 chromosome, complete genome Lineage: Polymorphum gilvum; Polymorphum; ; ; Proteobacteria; Bacteria General Information: Polymorphum gilvum SL003B-26A1 is a type strain of a newly published novel species in the novel genus Polymorphum. It was isolated from a crude oil-polluted saline soil in Shengli Oilfield, China and could use the crude oil as the sole carbon source. Oil pollution has become a global issue because of its severe ecological impact and destruction. Bioremediation is proved to be an effective process to restore the oil polluted environments. The complete genome sequence of Polymorphum gilvum SL003B-26A1 provides new strategies for bioremediation of oil contaminated environment.
- Sequence; - BLASTN hit (Low score = Light, High score = Dark) - hypothetical protein; - cds: hover for description
General Information: This strain (JCM 1112, F275) is the type strain for the species. It is a human isolate, which is unable to colonize the intestinal tract of mice. Normal gut bacterium. They are commonly found in the oral, vaginal, and intestinal tracts of many animals. They are important industrial microbes that contribute to the production of cheese, yogurt, and other products such as fermented milks, all stemming from the production of lactic acid, which inhibits the growth of other organisms as well as lowering the pH of the food product. Industrial production requires the use of starter cultures, which are carefully cultivated, created, and maintained. These cultures produce specific end products during fermentation that impart flavor to the final product, as well as contributing important metabolic reactions, such as the breakdown of milk proteins during cheese production. The end product of fermentation, lactic acid, is also used as a starter molecule for complex organic molecule syntheses. Lactobacillus reuteri is a member of the normal microbial community of the gut in humans and animals. This organism produces antibiotic compounds, such as reutericin and reuterin, which have inhibitory effects on pathogenic microorganisms.